Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planNo plan disclosedOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 2 of the 13 calendar months from Oct 2025 to Oct 2026: Feb 2026 and Mar 2026.
- Largest single sale: $14.8M (443,707 shares) of NewAmsterdam Pharma Co N.V. on Mar 2, 2026. Filing
- Last sale before this period: Mar 26, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| NewAmsterdam Pharma Co N.V. (NAMS) | Chief Executive Officer, Director | Dec 29, 2023 | Sep 15, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Sep 14, 2026, NewAmsterdam Pharma Co N.V.: bought 10,000 shares for $227K. 1 filing: 1
- Mar 2, 2026, NewAmsterdam Pharma Co N.V.: sold 443,707 shares for $14.8M, no plan disclosed; 443,707 shares acquired by exercising options. 1 filing: 1
- Feb 26, 2026, NewAmsterdam Pharma Co N.V.: sold 183,332 shares for $6.2M, under a disclosed plan; 183,332 shares acquired by exercising options. 1 filing: 1
- Feb 25, 2026, NewAmsterdam Pharma Co N.V.: sold 58,253 shares for $2.1M, under a disclosed plan; 58,253 shares acquired by exercising options. 1 filing: 1
- Feb 24, 2026, NewAmsterdam Pharma Co N.V.: sold 64,708 shares for $2.3M, under a disclosed plan; 64,708 shares acquired by exercising options. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.